FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
+34.41%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$2.13B
AUM Growth
+$2.13B
(+19%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $1.52B | 71.42% | 50,871,524 | – | – |
|
|
RUBY
2
DELISTED
Rubius Therapeutics, Inc
RUBY
| $170M | 7.99% | 38,296,526 | – | – |
|
3
Denali Therapeutics
DNLI
$2.23B
| $140M | 6.55% | 7,980,263 | – | – |
|
|
KLDO
4
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $107M | 5% | 17,360,710 | – | – |
|
5
Seres Therapeutics
MCRB
$166M
| $77M | 3.61% | 21,571,764 | – | – |
|
|
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $68.6M | 3.21% | 18,233,403 | – | – |
|
|
AXLA
7
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $29.9M | 1.4% | 8,748,414 | – | – |
|
|
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $17.4M | 0.82% | 2,938,494 | – | – |
|
9
Transmedics
TMDX
$3.92B
| – | – | 0 | – | – |
|